{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:05:24Z","timestamp":1779998724166,"version":"3.53.1"},"reference-count":143,"publisher":"Elsevier","isbn-type":[{"value":"9780443417610","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/01576"],"award-info":[{"award-number":["PI23\/01576"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["IDE\/2024\/00074"],"award-info":[{"award-number":["IDE\/2024\/00074"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009589","name":"Fundaci\u00f3n Lair","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDAS222516AGUI"],"award-info":[{"award-number":["PRDAS222516AGUI"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.ircmb.2026.02.003","type":"book-chapter","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:44:59Z","timestamp":1772109899000},"page":"173-199","source":"Crossref","is-referenced-by-count":0,"title":["The double-edged role of interferon gamma in\u00a0cancer immunity"],"prefix":"10.1016","author":[{"given":"Candelaria","family":"Aguilar-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mart\u00ednez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Granda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segundo","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.ircmb.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","article-title":"Suppressors of cytokine signalling (SOCS) in the immune system","volume":"2","author":"Alexander","year":"2002","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: Modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Antonelli","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1200\/JCO.1989.7.12.1875","article-title":"Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma","volume":"7","author":"Aulitzky","year":"1989","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1006\/bbrc.2001.6246","article-title":"INF-gamma rearranges membrane topography of MHC-I and ICAM-1 in colon carcinoma cells","volume":"290","author":"Bacso","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2643-3230.BCD-21-0181","article-title":"Blockade or deletion of ifngamma reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies","volume":"3","author":"Bailey","year":"2022","journal-title":"Blood Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/cr.2013.163","article-title":"Innate IFNgamma-producing B cells","volume":"24","author":"Ballesteros-Tato","year":"2014","journal-title":"Cell Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.275.5308.1930","article-title":"Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3","volume":"275","author":"Beals","year":"1997","journal-title":"Science (New York, N. Y. )"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.4049\/jimmunol.165.10.5502","article-title":"IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen","volume":"165","author":"Beatty","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbrc.2004.07.171","article-title":"Membrane topography of HLA I, HLA II, and ICAM-1 is affected by IFN-gamma in lipid rafts of uveal melanomas","volume":"322","author":"Bene","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1189\/jlb.70.6.950","article-title":"Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death","volume":"70","author":"Bernabei","year":"2001","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-gamma derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death & Disease"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s43018-023-00570-7","article-title":"Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-gamma is a major determinant of CD4(+) CAR T-cell antitumor activity","volume":"4","author":"Boulch","year":"2023","journal-title":"Nature Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4049\/jimmunol.157.4.1350","article-title":"A direct role for IFN-gamma in regulation of Th1 cell development","volume":"157","author":"Bradley","year":"1996","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.25350","article-title":"Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis","volume":"128","author":"Briesemeister","year":"2011","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib21","article-title":"STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-gamma\/TNF-alpha-induced apoptosis in NIT-1 cells","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.0903412","article-title":"Cutting edge: The Th1 response inhibits the generation of peripheral regulatory T cells","volume":"184","author":"Caretto","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: Therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1093\/emboj\/19.15.4111","article-title":"How Stat1 mediates constitutive gene expression: A complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene","volume":"19","author":"Chatterjee-Kishore","year":"2000","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ejh.13921","article-title":"Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia","volume":"110","author":"Chen","year":"2023","journal-title":"European Journal of Haematology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.272.5262.719","article-title":"Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1\/CIP1 mediated by STAT1","volume":"272","author":"Chin","year":"1996","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M403595200","article-title":"Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function","volume":"279","author":"Colvin","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1464-410X.2006.06451.x","article-title":"Carefully selected intratesticular lesions can be safely managed with serial ultrasonography","volume":"98","author":"Connolly","year":"2006","journal-title":"BJU International"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112907","article-title":"Viral recognition and the antiviral interferon response","volume":"42","author":"Dalskov","year":"2023","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/849573","article-title":"Epigenetic control of interferon-gamma expression in CD8 T cells","volume":"2015","author":"De Araujo-Souza","year":"2015","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/j.1460-2075.1991.tb08026.x","article-title":"Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor","volume":"10","author":"Decker","year":"1991","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.49.2.251","article-title":"Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis","volume":"49","author":"Detjen","year":"2001","journal-title":"Gut"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","article-title":"MAP kinases in the immune response","volume":"20","author":"Dong","year":"2002","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41590-022-01315-x","article-title":"In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer","volume":"23","author":"Dubrot","year":"2022","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.24401","article-title":"Interferon-gamma reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages","volume":"125","author":"Duluc","year":"2009","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/mt.2010.52","article-title":"Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas","volume":"18","author":"Dummer","year":"2010","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1385\/IR:32:1-3:231","article-title":"Interferon-gamma and cancer immunoediting","volume":"32","author":"Dunn","year":"2005","journal-title":"Immunologic Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13008-016-0023-4","article-title":"Interferon gamma-induced apoptosis of head and neck squamous cell carcinoma is connected to indoleamine-2,3-dioxygenase via mitochondrial and ER stress-associated pathways","volume":"11","author":"El Jamal","year":"2016","journal-title":"Cell Division"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1962591","article-title":"IFN-gamma-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells","volume":"10","author":"Fang","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1471-4906(01)02005-1","article-title":"IFN-gamma production by antigen-presenting cells: Mechanisms emerge","volume":"22","author":"Frucht","year":"2001","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1002\/j.1460-2075.1988.tb03213.x","article-title":"Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements","volume":"7","author":"Fujita","year":"1988","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib44","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib45","first-page":"377","article-title":"Interferon-gamma: Biologic functions and HCV therapy (type I\/II) (1 of 2 parts)","volume":"157","author":"Gattoni","year":"2006","journal-title":"La Clinica Terapeutica"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/eji.1830260329","article-title":"Autocrine activation by interferon-gamma of STAT factors following T cell activation","volume":"26","author":"Girdlestone","year":"1996","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199804303381804","article-title":"Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group","volume":"338","author":"Gleave","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: Teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41467-017-00925-6","article-title":"Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration","volume":"8","author":"Gordon-Alonso","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved interferon-gamma signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cytogfr.2016.02.006","article-title":"Monocyte and interferon based therapy for the treatment of ovarian cancer","volume":"29","author":"Green","year":"2016","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0300-9084(01)01251-2","article-title":"Interferon-gamma inducible exchanges of 20S proteasome active site subunits: Why?","volume":"83","author":"Groettrup","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","article-title":"Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma","volume":"164","author":"Haber","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-gamma signaling and response: The barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1349-7006.2011.02042.x","article-title":"Early activation and interferon-gamma production of tumor-infiltrating mature CD27 high natural killer cells","volume":"102","author":"Hayakawa","year":"2011","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1158\/1078-0432.CCR-17-3451","article-title":"Interferon gamma messenger RNA signature in tumor biopsies predicts outcomes in patients with non-small cell lung carcinoma or urothelial cancer treated with durvalumab","volume":"24","author":"Higgs","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009410","article-title":"IFNgamma mediates the resistance of tumor cells to distinct NK cell subsets","volume":"12","author":"Hofman","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12032-022-01724-w","article-title":"The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies","volume":"39","author":"Hosseinalizadeh","year":"2022","journal-title":"Medical Oncology (Northwood, London, England)"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jss.2019.02.038","article-title":"IFN-gamma promotes epithelial-mesenchymal transition and the expression of PD-L1 in pancreatic cancer","volume":"240","author":"Imai","year":"2019","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/GCO.0b013e3283409c79","article-title":"Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer","volume":"23","author":"Ino","year":"2011","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: Signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.4049\/jimmunol.1000154","article-title":"Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway","volume":"185","author":"Jeon","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729359","article-title":"Construction of interferon-gamma-related gene signature to characterize the immune-inflamed phenotype of glioblastoma and predict prognosis, efficacy of immunotherapy and radiotherapy","volume":"12","author":"Ji","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib65","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1158\/1078-0432.CCR-18-0309","article-title":"Quantitative spatial profiling of PD-1\/PD-L1 interaction and HLA-DR\/IDO-1 predicts improved outcomes of anti-PD-1 therapies in metastatic melanoma","volume":"24","author":"Johnson","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-gamma in tumor progression and regression: A review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomarker Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.21873\/anticanres.14251","article-title":"Significance of quantitative interferon-gamma levels in non-small-cell lung cancer patients' response to immune checkpoint inhibitors","volume":"40","author":"Kanai","year":"2020","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib70","doi-asserted-by":"crossref","DOI":"10.1177\/1758834017749748","article-title":"Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients","volume":"10","author":"Karachaliou","year":"2018","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1158\/2326-6066.CIR-22-0815","article-title":"High expression of MHC class I overcomes cancer immunotherapy resistance due to IFNgamma signaling pathway defects","volume":"11","author":"Kawase","year":"2023","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib72","first-page":"4020","article-title":"Enhancement of metastatic potential by gamma-interferon","volume":"51","author":"Kelly","year":"1991","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1182\/blood.V98.5.1480","article-title":"Regulation of interferon-gamma gene expression by nuclear factor of activated T cells","volume":"98","author":"Kiani","year":"2001","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib74","first-page":"804","article-title":"Gamma interferon therapy of cancer patients","volume":"15","author":"Kobayashi","year":"1988","journal-title":"Gan To Kagaku Ryoho. Cancer & Chemotherapy"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cytogfr.2016.07.005","article-title":"The untold story of IFN-gamma in cancer biology","volume":"31","author":"Kursunel","year":"2016","journal-title":"Cytokine & Growth Factor Reviews"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib76","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.1986.4.11.1677","article-title":"Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients","volume":"4","author":"Kurzrock","year":"1986","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFNgammaR pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.febslet.2005.12.093","article-title":"Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274)","volume":"580","author":"Lee","year":"2006","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib79","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-10-142","article-title":"Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells","volume":"10","author":"Lesinski","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib80","article-title":"A high interferon gamma signature of CD8(+) T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer","volume":"13","author":"Li","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cas.15575","article-title":"Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma","volume":"114","author":"Lorenzo-Herrero","year":"2023","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib82","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41467-023-38723-y","article-title":"Neutralizing IFNgamma improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies","volume":"14","author":"Manni","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40364-024-00671-0","article-title":"Deciphering LAG-3: Unveiling molecular mechanisms and clinical advancements","volume":"12","author":"Martinez-Perez","year":"2024","journal-title":"Biomarker Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib84","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-21-3226","article-title":"IFNgamma signaling in natural and therapy-induced antitumor responses","volume":"28","author":"Martinez-Sabadell","year":"2022","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib85","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1016\/j.vaccine.2010.03.007","article-title":"IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer","volume":"28","author":"Martini","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib86","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/1521-4141(200107)31:7<2236::AID-IMMU2236>3.0.CO;2-G","article-title":"IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: Differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12","volume":"31","author":"Matikainen","year":"2001","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib87","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41586-019-0988-7","article-title":"Structure of the IFNgamma receptor complex guides design of biased agonists","volume":"567","author":"Mendoza","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010089","article-title":"The dark side of IFN-gamma: Its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib89","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013598","article-title":"Myeloid cell-based delivery of IFN-gamma reprograms the leukemia microenvironment and induces anti-tumoral immune responses","volume":"13","author":"Mucci","year":"2021","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib90","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.168.3.1146","article-title":"Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1","volume":"168","author":"Nakahira","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/76940","article-title":"Interferon alpha\/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox","volume":"1","author":"Nguyen","year":"2000","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib93","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-gamma drives T(reg) fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib94","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2009.09.009","article-title":"Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function","volume":"30","author":"Palmer","year":"2009","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-024-01972-6","article-title":"CTLs heterogeneity and plasticity: Implications for cancer immunotherapy","volume":"23","author":"Peng","year":"2024","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib96","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12974-018-1330-2","article-title":"The IFN-gamma\/PD-L1 axis between T cells and tumor microenvironment: Hints for glioma anti-PD-1\/PD-L1 therapy","volume":"15","author":"Qian","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib97","first-page":"43","article-title":"Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction","volume":"4","author":"Qiu","year":"2023","journal-title":"Nature Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jbiotec.2016.10.022","article-title":"Review of the recombinant human interferon gamma as an immunotherapeutic: Impacts of production platforms and glycosylation","volume":"240","author":"Razaghi","year":"2016","journal-title":"Journal of Biotechnology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0002-9440(10)64171-5","article-title":"Expression of IP-10\/CXCL10 and MIG\/CXCL9 in the thyroid and increased levels of IP-10\/CXCL10 in the serum of patients with recent-onset Graves' disease","volume":"161","author":"Romagnani","year":"2002","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Advances in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: An overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.910595","article-title":"Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies","volume":"13","author":"Seliger","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10428194.2022.2131408","article-title":"IFN-gamma enhances CLL cell resistance to ABT-199 by regulating MCL-1 and BCL-2 expression via the JAK-STAT3 signaling pathway","volume":"64","author":"Shao","year":"2023","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.119052","article-title":"Light emitting CMC-CHO based self-healing hydrogel with injectability for in vivo wound repairing applications","volume":"281","author":"Shen","year":"2022","journal-title":"Carbohydrate Polymers"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib107","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discovery"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib108","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1073\/pnas.0400849101","article-title":"Evolutionarily conserved sequence elements that positively regulate IFN-gamma expression in T cells","volume":"101","author":"Shnyreva","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib109","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0008-8749(88)90109-8","article-title":"Effects of interferon-gamma on the activation of human T lymphocytes","volume":"111","author":"Siegel","year":"1988","journal-title":"Cellular Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib110","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/gut.2009.194472","article-title":"Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer","volume":"59","author":"Simpson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib111","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib112","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccell.2023.02.013","article-title":"Mutations in IFN-gamma signaling genes sensitize tumors to immune checkpoint blockade","volume":"41","author":"Song","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib113","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/imcb.12287","article-title":"Differential interferon-gamma production potential among naive CD4(+) T cells exists prior to antigen encounter","volume":"97","author":"Sood","year":"2019","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib114","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.169.12.6664","article-title":"Cutting edge: Distal regulatory elements are required to achieve selective expression of IFN-gamma in Th1\/Tc1 effector cells","volume":"169","author":"Soutto","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3565(25)30128-X","article-title":"Desensitization of the adrenergic neurons of the isolated rabbit ear artery to nicotinic agonists","volume":"193","author":"Steinsland","year":"1975","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib116","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.170.11.5464","article-title":"IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells","volume":"170","author":"Strengell","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib117","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ni.3205","article-title":"Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation","volume":"16","author":"Su","year":"2015","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib118","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ccell.2021.08.005","article-title":"Activating a collaborative innate-adaptive immune response to control metastasis","volume":"39","author":"Sun","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229252","article-title":"STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability","volume":"15","author":"Tanaka","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jlb.56.5.571","article-title":"Role of proteasomes modified by interferon-gamma in antigen processing","volume":"56","author":"Tanaka","year":"1994","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216798","article-title":"Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer","volume":"588","author":"Tang","year":"2024","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib122","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/MCB.05445-11","article-title":"NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis","volume":"31","author":"Thapa","year":"2011","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib123","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.18632\/oncotarget.7750","article-title":"An increase in galectin-3 causes cellular unresponsiveness to IFN-gamma-induced signal transduction and growth inhibition in gastric cancer cells","volume":"7","author":"Tseng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib124","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0952-7915(99)80034-X","article-title":"Specificity of the proteasome and the TAP transporter","volume":"11","author":"Uebel","year":"1999","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008125","article-title":"Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma","volume":"12","author":"Versluis","year":"2024","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib126","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1353856","article-title":"Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia","volume":"6","author":"Villa-Alvarez","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib127","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3389\/fimmu.2018.02917","article-title":"Ig-Like transcript 2 (ILT2) blockade and lenalidomide restore NK cell function in chronic lymphocytic leukemia","volume":"9","author":"Villa-Alvarez","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib128","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41467-024-45916-6","article-title":"Comprehensive characterization of IFNgamma signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12102","article-title":"Integrated molecular analyses of an interferon-gamma based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification","volume":"8","author":"Wang","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.bbrc.2018.03.118","article-title":"Interferon-gamma induces autophagy-associated apoptosis through induction of cPLA2-dependent mitochondrial ROS generation in colorectal cancer cells","volume":"498","author":"Wang","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/ceo.12268","article-title":"Interferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon's fibroblasts","volume":"42","author":"Wang","year":"2014","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib132","first-page":"2832","article-title":"IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression","volume":"58","author":"Xu","year":"1998","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib133","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.18632\/aging.202831","article-title":"Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma","volume":"13","author":"Yao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib134","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The interferon-gamma paradox in cancer","volume":"39","author":"Zaidi","year":"2019","journal-title":"Journal of Interferon & Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib137","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-gamma in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib138","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.2016005","article-title":"IL-6\/IFN-gamma double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro","volume":"18","author":"Zhang","year":"2022","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/jir.2018.0070","article-title":"Interferon gamma inhibits CXCL8-induced proliferation and migration of pancreatic cancer BxPC-3 cell line via a RhoGDI2\/Rac1\/NF-kappaB signaling pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Journal of Interferon & Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib141","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.7314\/APJCP.2013.14.9.5513","article-title":"Anti-proliferation effects of interferon-gamma on gastric cancer cells","volume":"14","author":"Zhao","year":"2013","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib142","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"International Reviews of Immunology"},{"key":"10.1016\/bs.ircmb.2026.02.003_bib143","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1038\/s41467-023-40028-z","article-title":"A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors","volume":"14","author":"Zibelman","year":"2023","journal-title":"Nature Communications"}],"container-title":["International Review of Cell and Molecular Biology","Cytokine-based immunotherapy - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644826000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644826000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:46:02Z","timestamp":1779997562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644826000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443417610"],"references-count":143,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2026.02.003","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}